Pediatric cancer prediction is revolutionizing the way we approach childhood malignancies, particularly through the integration of advanced AI technologies.Recent studies reveal that artificial intelligence (AI) tools can significantly enhance the accuracy of relapse risk evaluations in young patients with brain tumors, such as gliomas.